This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
4, 2025 Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 new customers with its ClearRead solutions to clearly, confidently and quickly detect cardiothoracic diseases. Our 2024 growth was driven by strong product market acceptance through network effects. MD, Thrap, K.,
milla1cf Mon, 06/17/2024 - 20:34 June 17, 2024 — aycan , a recognized leader in medical imaging, announced today a reseller and technology partnership with AI4MedImaging, a company that specializes in applying artificial intelligence ( AI ) to medical imaging. and Germany.
RCE Technologies, Inc. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24 Featured in an ACC.24 Featured in an ACC.24
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. christine.book Wed, 03/06/2024 - 14:51 March 6, 2024 — Bodyport Inc. ,
Getty Images milla1cf Wed, 03/06/2024 - 18:45 March 6, 2024 — Ensight-AI , a Yale start-up and leader in AI -based cardiovascular diagnostics, announces the receipt of the U.S. Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy.
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash.,
milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc.announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. electrophysiology labs. I am hopeful that Heart Rhythm Society’s conference will reflect this.”
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
milla1cf Thu, 03/07/2024 - 20:10 March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence ( AI )-enabled medical devices and digital solutions in Booth 2500 at the Health Information and Management Systems Society ( HIMSS ) Global Health Conference and Exhibition in Orlando, FL from March 11-15, 2024.
milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.
tim.hodson Tue, 06/11/2024 - 17:21 On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI." This webinar will delve into the key elements of an ideal system that can streamline processes, improve efficiency, and enhance patientcare.
mtaschetta-millane Thu, 07/11/2024 - 11:01 July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK ’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.
mtaschetta-millane Tue, 07/16/2024 - 09:59 July 16, 2024 — Arineta , a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly announces the latest installation of its SpotLight Duo at Cardiovascular Consultants, Ltd. (CVC) CVC) in Arizona. sec per rotation.
mtaschetta-millane Thu, 07/18/2024 - 10:00 July 18, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced the next generation HeartFlow Plaque Analysis with an interactive experience. JSCAI 2024. F.A.C.C. “The Narula et al. Rinehart et al.
In the fast-evolving world of medical technology, continuous glucose monitors (CGMs) are making headlines. Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients.
milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM. “At
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patientcare through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
milla1cf Thu, 04/04/2024 - 12:14 April 4, 2024 — Osso VR , a leader in immersive procedural training, announces the release of a co-developed curriculum with the American College of Cardiology ( ACC ). Both Osso VR and the American College of Cardiology are committed to excellence in medical education and patientcare.
milla1cf Tue, 05/07/2024 - 12:54 May 7, 2024 — HonorHealth Research Institute ’s David G. Instead, they focused almost exclusively on their ability to provide ever-improving patientcare. Their obsession was patientcare: new and novel technologies, research and finding ways to treat patients.
It might have been graduation time in many parts of Boston last weekend, but an electrophysiology family reunion was taking place in the city’s Seaport district, bringing the latest in EP science, technology, and patientcare. The post Cardiac Wire’s Top Six Takeaways from HRS 2024 appeared first on Cardiac Wire.
milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.
With AngioFlow by RapidAI, we can now support stroke AI imaging along the entire patient pathway, from the initial non-contrast CT scan all the way to the interventional suite,” said Karim Karti , CEO of RapidAI. Already registered and used in Japan and Europe, we believe this technology will make a significant difference in the lives of U.S.
The American College of Cardiology has released a workbook on remote patient management (RPM), which aims to guide CV care professionals on definitions, clinical uses, benefits and limitations. Cardiovascular clinicians report an increase in patients using consumer-grade RPM products, such as smart watches and other wearables.
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patientcare in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.
Cambridge, MA-based artificial intelligence (AI)-driven health technology company, Anumana, has announced its receipt of the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. ECG-AI LEF, the company’s breakthrough AI algorithm, received U.S. More information: www.anumana.ai
Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.
milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024.
16, 2024 at the age of 79. Cribier always remained humble and committed to his colleagues and the betterment of patientcare. This last breakthrough technology, now widely used throughout the world, changed the face of medical practice. He passed away Feb.
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world. Together, we will build upon our shared legacies of enhancing patientcare.”
The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health. Staying informed about these cutting-edge developments is critical for providing exceptional patientcare. Join us as we examine the landmark approvals that are revolutionizing patient outcomes.
tim.hodson Wed, 10/16/2024 - 14:46 Oct. 11, 2024 – As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers. This full-day event, organized by a partnership among the Cardiovascular Research Foundation (CRF), Fogarty Innovation and the FDA, launches TCT 2024.
As we step into 2024, the evolution of Electronic Health Records (EHR) software continues to shape the future of healthcare. In an era marked by rapid technological advancements, the influence of EHR software on healthcare is more profound than ever. The post 10 Trends for 2024 Cardiology EHR Software appeared first on GEMMS.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.
electrophysiology labs, and will be participating in the Heart Rhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc. milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc. Innovative Health, Inc.
Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38
milla1cf Wed, 04/03/2024 - 18:58 April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL.
Pankaj Garg, MD mtaschetta-millane Fri, 07/12/2024 - 11:14 July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artificial intelligence , which could save valuable NHS time and resources, as well as improve care for patients.
Furthermore, we investigate the technology and systems in place to aid staff in this endeavour. By rectifying these coding discrepancies, we can enhance patientcare, minimise potential oversights, and ultimately improve outcomes for individuals living with HF.
In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. For reporting in 2024, 25% of total score applies to Promoting Interoperability.
Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” VIVID study The VIVID study is a global, prospective, multi-center, single-arm, non-blinded clinical trial conducted in the U.S.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content